Clinical Trial

A Nasal Treatment for COVID-19

Name: A Nasal Treatment for COVID-19 — clinical trial record (NCT05799521)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: COVD-TX

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this study is to test an investigational new inhaled medication called Optate.

Protocol Amendment History 2 changes

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-29

notable Enrollment reduced: 40 -> 24 participants 2026-05-29

Trial Details

NCT Number	NCT05799521
Lead Sponsor	Indiana University
Conditions	COVID-19, Healthy
Enrollment	24 participants
Start Date	2023-06-27
Primary Completion	2027-03-30 (estimated)
Study Completion	2027-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-28